SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-109860
Filing Date
2023-10-18
Accepted
2023-10-18 16:09:47
Documents
16
Period of Report
2023-10-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328636d1_8k.htm   iXBRL 8-K 56095
2 EXHIBIT 10.1 tm2328636d1_ex10-1.htm EX-10.1 85643
3 EXHIBIT 10.2 tm2328636d1_ex10-2.htm EX-10.2 67817
4 EXHIBIT 99.1 tm2328636d1_ex99-1.htm EX-99.1 17673
8 GRAPHIC tm2328636d1_ex99-1img001.jpg GRAPHIC 12204
  Complete submission text file 0001104659-23-109860.txt   474305

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ymab-20231012.xsd EX-101.SCH 3006
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymab-20231012_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymab-20231012_pre.xml EX-101.PRE 22353
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2328636d1_8k_htm.xml XML 3306
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 231332349
SIC: 2834 Pharmaceutical Preparations